Do analysts rate CBT or IOSP?

Cabot currently has a consensus target price of $89.00, suggesting a potential upside of 16.65%. Given Cabot's stronger consensus rating and higher possible upside, analysts clearly believe Cabot is more favorable than Innospec. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cabot 1 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14 Innospec 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings and valuation, CBT or IOSP?

Cabot has higher revenue and earnings than Innospec. Innospec is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cabot $3.71B 1.06 $331M $3.55 21.49 Innospec $1.78B 1.32 $116.60M $4.90 19.42

Is CBT or IOSP more profitable?

Innospec has a net margin of 6.60% compared to Cabot's net margin of 5.23%. Cabot's return on equity of 20.29% beat Innospec's return on equity. Company Net Margins Return on Equity Return on Assets Cabot 5.23% 20.29% 9.01% Innospec 6.60% 9.22% 6.74%

Does the media prefer CBT or IOSP?

In the previous week, Innospec had 4 more articles in the media than Cabot. MarketBeat recorded 6 mentions for Innospec and 2 mentions for Cabot. Cabot's average media sentiment score of 0.51 beat Innospec's score of 0.14 indicating that Cabot is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cabot 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Innospec 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Is CBT or UFPI more profitable?

Cabot has a net margin of 5.23% compared to UFP Industries' net margin of 3.99%. Cabot's return on equity of 20.29% beat UFP Industries' return on equity. Company Net Margins Return on Equity Return on Assets Cabot 5.23% 20.29% 9.01% UFP Industries 3.99% 8.00% 6.11%

Does the media favor CBT or UFPI?

In the previous week, UFP Industries had 8 more articles in the media than Cabot. MarketBeat recorded 10 mentions for UFP Industries and 2 mentions for Cabot. Cabot's average media sentiment score of 0.51 beat UFP Industries' score of 0.05 indicating that Cabot is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cabot 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive UFP Industries 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, CBT or ASIX?

Cabot has higher revenue and earnings than AdvanSix. AdvanSix is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cabot $3.71B 1.06 $331M $3.55 21.49 AdvanSix $1.52B 0.28 $49.29M -$0.66 N/A

Is CBT or ASIX more profitable?

Cabot has a net margin of 5.23% compared to AdvanSix's net margin of -1.14%. Cabot's return on equity of 20.29% beat AdvanSix's return on equity. Company Net Margins Return on Equity Return on Assets Cabot 5.23% 20.29% 9.01% AdvanSix -1.14% -1.28% -0.61%

Does the media refer more to CBT or ASIX?

In the previous week, Cabot had 1 more articles in the media than AdvanSix. MarketBeat recorded 2 mentions for Cabot and 1 mentions for AdvanSix. AdvanSix's average media sentiment score of 1.22 beat Cabot's score of 0.51 indicating that AdvanSix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cabot 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AdvanSix 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, AVNT or CBT?

Cabot has higher revenue and earnings than Avient. Cabot is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avient $3.26B 1.14 $81.90M $1.85 21.87 Cabot $3.71B 1.06 $331M $3.55 21.49

Is AVNT or CBT more profitable?

Cabot has a net margin of 5.23% compared to Avient's net margin of 5.10%. Cabot's return on equity of 20.29% beat Avient's return on equity. Company Net Margins Return on Equity Return on Assets Avient 5.10% 11.64% 4.67% Cabot 5.23% 20.29% 9.01%

Does the media prefer AVNT or CBT?

In the previous week, Avient had 4 more articles in the media than Cabot. MarketBeat recorded 6 mentions for Avient and 2 mentions for Cabot. Cabot's average media sentiment score of 0.51 beat Avient's score of 0.50 indicating that Cabot is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avient 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cabot 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is CC or CBT more profitable?

Cabot has a net margin of 5.23% compared to Chemours' net margin of -5.00%. Chemours' return on equity of 60.64% beat Cabot's return on equity. Company Net Margins Return on Equity Return on Assets Chemours -5.00% 60.64% 1.48% Cabot 5.23% 20.29% 9.01%

Does the media favor CC or CBT?

In the previous week, Chemours had 6 more articles in the media than Cabot. MarketBeat recorded 8 mentions for Chemours and 2 mentions for Cabot. Cabot's average media sentiment score of 0.51 beat Chemours' score of 0.15 indicating that Cabot is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemours 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Cabot 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Cabot (CBT) Competitors

$76.29 -0.62 (-0.80%)

Closing price 10/1/2026 03:59 PM Eastern

Extended Trading

$76.40 +0.10 (+0.13%)

As of 10/1/2026 07:35 PM Eastern

Compare

CBT vs. IOSP, UFPI, ASIX, AVNT, and CC

Should you buy Cabot stock or one of its competitors? Cabot's main competitors and comparable companies include Innospec (IOSP), UFP Industries (UFPI), AdvanSix (ASIX), Avient (AVNT), and Chemours (CC). Companies are selected based on similarities in market, industry, and size.

How does Cabot compare to Innospec?

Cabot (NYSE:CBT) and Innospec (NASDAQ:IOSP) are both mid-cap materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.

Cabot currently has a consensus target price of $89.00, suggesting a potential upside of 16.65%. Given Cabot's stronger consensus rating and higher possible upside, analysts clearly believe Cabot is more favorable than Innospec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cabot	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
Innospec	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

93.2% of Cabot shares are owned by institutional investors. Comparatively, 96.6% of Innospec shares are owned by institutional investors. 3.1% of Cabot shares are owned by insiders. Comparatively, 1.5% of Innospec shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cabot has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, Innospec has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market.

Cabot has higher revenue and earnings than Innospec. Innospec is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cabot	$3.71B	1.06	$331M	$3.55	21.49
Innospec	$1.78B	1.32	$116.60M	$4.90	19.42

In the previous week, Innospec had 4 more articles in the media than Cabot. MarketBeat recorded 6 mentions for Innospec and 2 mentions for Cabot. Cabot's average media sentiment score of 0.51 beat Innospec's score of 0.14 indicating that Cabot is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cabot	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Innospec	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.5%. Innospec pays an annual dividend of $1.84 per share and has a dividend yield of 1.9%. Cabot pays out 53.2% of its earnings in the form of a dividend. Innospec pays out 37.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has raised its dividend for 14 consecutive years and Innospec has raised its dividend for 11 consecutive years. Cabot is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Innospec has a net margin of 6.60% compared to Cabot's net margin of 5.23%. Cabot's return on equity of 20.29% beat Innospec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cabot	5.23%	20.29%	9.01%
Innospec	6.60%	9.22%	6.74%

Summary

Cabot beats Innospec on 12 of the 19 factors compared between the two stocks.

How does Cabot compare to UFP Industries?

Cabot (NYSE:CBT) and UFP Industries (NASDAQ:UFPI) are related mid-cap companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Cabot has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, UFP Industries has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market.

Cabot has higher earnings, but lower revenue than UFP Industries. UFP Industries is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cabot	$3.71B	1.06	$331M	$3.55	21.49
UFP Industries	$6.32B	0.67	$294.79M	$4.36	17.68

93.2% of Cabot shares are held by institutional investors. Comparatively, 81.8% of UFP Industries shares are held by institutional investors. 3.1% of Cabot shares are held by insiders. Comparatively, 2.5% of UFP Industries shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, UFP Industries had 8 more articles in the media than Cabot. MarketBeat recorded 10 mentions for UFP Industries and 2 mentions for Cabot. Cabot's average media sentiment score of 0.51 beat UFP Industries' score of 0.05 indicating that Cabot is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cabot	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UFP Industries	1 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cabot has a net margin of 5.23% compared to UFP Industries' net margin of 3.99%. Cabot's return on equity of 20.29% beat UFP Industries' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cabot	5.23%	20.29%	9.01%
UFP Industries	3.99%	8.00%	6.11%

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.5%. UFP Industries pays an annual dividend of $1.44 per share and has a dividend yield of 1.9%. Cabot pays out 53.2% of its earnings in the form of a dividend. UFP Industries pays out 33.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has raised its dividend for 14 consecutive years and UFP Industries has raised its dividend for 5 consecutive years. Cabot is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cabot currently has a consensus target price of $89.00, indicating a potential upside of 16.65%. UFP Industries has a consensus target price of $104.50, indicating a potential upside of 35.57%. Given UFP Industries' stronger consensus rating and higher possible upside, analysts clearly believe UFP Industries is more favorable than Cabot.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cabot	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
UFP Industries	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43

Summary

Cabot beats UFP Industries on 11 of the 19 factors compared between the two stocks.

How does Cabot compare to AdvanSix?

Cabot (NYSE:CBT) and AdvanSix (NYSE:ASIX) are both materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, media sentiment, risk, dividends and valuation.

Cabot has higher revenue and earnings than AdvanSix. AdvanSix is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cabot	$3.71B	1.06	$331M	$3.55	21.49
AdvanSix	$1.52B	0.28	$49.29M	-$0.66	N/A

93.2% of Cabot shares are owned by institutional investors. Comparatively, 86.4% of AdvanSix shares are owned by institutional investors. 3.1% of Cabot shares are owned by company insiders. Comparatively, 5.0% of AdvanSix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.5%. AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 4.0%. Cabot pays out 53.2% of its earnings in the form of a dividend. AdvanSix pays out -97.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has raised its dividend for 14 consecutive years and AdvanSix has raised its dividend for 2 consecutive years. AdvanSix is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Cabot had 1 more articles in the media than AdvanSix. MarketBeat recorded 2 mentions for Cabot and 1 mentions for AdvanSix. AdvanSix's average media sentiment score of 1.22 beat Cabot's score of 0.51 indicating that AdvanSix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cabot	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AdvanSix	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cabot presently has a consensus price target of $89.00, suggesting a potential upside of 16.65%. AdvanSix has a consensus price target of $21.50, suggesting a potential upside of 34.32%. Given AdvanSix's higher possible upside, analysts plainly believe AdvanSix is more favorable than Cabot.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cabot	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
AdvanSix	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Cabot has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market. Comparatively, AdvanSix has a beta of 1.34, meaning that its stock price is 34% more volatile than the broader market.

Cabot has a net margin of 5.23% compared to AdvanSix's net margin of -1.14%. Cabot's return on equity of 20.29% beat AdvanSix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cabot	5.23%	20.29%	9.01%
AdvanSix	-1.14%	-1.28%	-0.61%

Summary

Cabot beats AdvanSix on 13 of the 19 factors compared between the two stocks.

How does Cabot compare to Avient?

Avient (NYSE:AVNT) and Cabot (NYSE:CBT) are both mid-cap materials companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation and profitability.

Avient has a beta of 1.28, suggesting that its share price is 28% more volatile than the broader market. Comparatively, Cabot has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market.

Avient presently has a consensus target price of $46.71, indicating a potential upside of 15.44%. Cabot has a consensus target price of $89.00, indicating a potential upside of 16.65%. Given Cabot's higher possible upside, analysts clearly believe Cabot is more favorable than Avient.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avient	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.83
Cabot	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14

Avient pays an annual dividend of $1.10 per share and has a dividend yield of 2.7%. Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.5%. Avient pays out 59.5% of its earnings in the form of a dividend. Cabot pays out 53.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Avient has raised its dividend for 1 consecutive years and Cabot has raised its dividend for 14 consecutive years.

95.5% of Avient shares are owned by institutional investors. Comparatively, 93.2% of Cabot shares are owned by institutional investors. 0.9% of Avient shares are owned by company insiders. Comparatively, 3.1% of Cabot shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Avient had 4 more articles in the media than Cabot. MarketBeat recorded 6 mentions for Avient and 2 mentions for Cabot. Cabot's average media sentiment score of 0.51 beat Avient's score of 0.50 indicating that Cabot is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avient	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cabot	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cabot has higher revenue and earnings than Avient. Cabot is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avient	$3.26B	1.14	$81.90M	$1.85	21.87
Cabot	$3.71B	1.06	$331M	$3.55	21.49

Cabot has a net margin of 5.23% compared to Avient's net margin of 5.10%. Cabot's return on equity of 20.29% beat Avient's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avient	5.10%	11.64%	4.67%
Cabot	5.23%	20.29%	9.01%

Summary

Cabot beats Avient on 11 of the 20 factors compared between the two stocks.

How does Cabot compare to Chemours?

Chemours (NYSE:CC) and Cabot (NYSE:CBT) are both mid-cap materials companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends.

In the previous week, Chemours had 6 more articles in the media than Cabot. MarketBeat recorded 8 mentions for Chemours and 2 mentions for Cabot. Cabot's average media sentiment score of 0.51 beat Chemours' score of 0.15 indicating that Cabot is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemours	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cabot	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Chemours has a beta of 1.41, meaning that its share price is 41% more volatile than the broader market. Comparatively, Cabot has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market.

Cabot has a net margin of 5.23% compared to Chemours' net margin of -5.00%. Chemours' return on equity of 60.64% beat Cabot's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemours	-5.00%	60.64%	1.48%
Cabot	5.23%	20.29%	9.01%

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.6%. Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.5%. Chemours pays out -18.3% of its earnings in the form of a dividend. Cabot pays out 53.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has increased its dividend for 14 consecutive years. Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio.

Chemours presently has a consensus target price of $19.70, indicating a potential upside of 46.42%. Cabot has a consensus target price of $89.00, indicating a potential upside of 16.65%. Given Chemours' stronger consensus rating and higher probable upside, analysts clearly believe Chemours is more favorable than Cabot.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	1 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.33
Cabot	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14

76.3% of Chemours shares are owned by institutional investors. Comparatively, 93.2% of Cabot shares are owned by institutional investors. 0.9% of Chemours shares are owned by insiders. Comparatively, 3.1% of Cabot shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Cabot has lower revenue, but higher earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemours	$5.81B	0.35	-$386M	-$1.91	N/A
Cabot	$3.71B	1.06	$331M	$3.55	21.49

Summary

Cabot beats Chemours on 10 of the 19 factors compared between the two stocks.

Get Cabot News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CBT vs. The Competition

Export

Metric	Cabot	Chemicals Industry	Materials Sector	NYSE Exchange
Market Cap	$3.97B	$11.16B	$4.71B	$22.63B
Dividend Yield	2.46%	2.95%	4.75%	3.74%
P/E Ratio	21.49	37.25	25.10	27.58
Price / Sales	1.06	55.20	16,699.85	20.54
Price / Cash	7.40	14.76	24.99	39.56
Price / Book	2.38	3.14	10.18	4.62
Net Income	$331M	$225.75M	$158.44M	$1.08B
7 Day Performance	-3.24%	-1.68%	-2.74%	-1.52%
1 Month Performance	-7.97%	-4.88%	-4.39%	-5.48%
1 Year Performance	0.91%	15.78%	17.75%	5.05%

Cabot Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CBT Cabot	3.5594 of 5 stars	$76.29 -0.8%	$89.00 +16.7%	+1.3%	$3.97B	$3.71B	21.49	4,100	Positive News
IOSP Innospec	3.1302 of 5 stars	$97.88 -0.9%	N/A	+23.9%	$2.43B	$1.78B	19.98	2,450
UFPI UFP Industries	4.7539 of 5 stars	$79.42 -0.1%	$104.50 +31.6%	-17.1%	$4.38B	$6.32B	18.22	13,800	Analyst Forecast
ASIX AdvanSix	4.0598 of 5 stars	$15.81 +0.1%	$21.50 +36.0%	-15.7%	$426.62M	$1.52B	N/A	1,410
AVNT Avient	3.944 of 5 stars	$41.21 -0.2%	$46.71 +13.3%	+26.3%	$3.79B	$3.26B	22.28	9,000	News Coverage Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CBT) was last updated on 10/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cabot (CBT) Competitors